Provided by Tiger Trade Technology Pte. Ltd.

Erasca, Inc.

17.45
-0.1850-1.05%
Volume:742.18K
Turnover:12.77M
Market Cap:6.10B
PE:-17.97
High:18.55
Open:18.37
Low:16.88
Close:17.63
52wk High:24.28
52wk Low:1.33
Shares:349.76M
Float Shares:291.15M
Volume Ratio:0.77
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9710
EPS(LYR):-0.4393
ROE:-78.25%
ROA:-21.39%
PB:16.86
PE(LYR):-39.71

Loading ...

Erasca Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Mar 14

Stock Track | Erasca Plummets 5.39% Intraday After Bank of America Maintains Sell Rating with $2 Target

Stock Track
·
Mar 14

Stock Track | Erasca Soars 5.12% Intraday on Positive Analyst Actions Including Price Target Hikes

Stock Track
·
Mar 13

Erasca Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 13

Mizuho Raises Price Target on Erasca to $19 From $16, Keeps Outperform Rating

MT Newswires Live
·
Mar 13

Erasca, Inc. : H.c. Wainwright Raises Target Price to $20 From $15

THOMSON REUTERS
·
Mar 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 13

U.S. RESEARCH ROUNDUP-Adobe, KLA, Ulta Beauty

Reuters
·
Mar 13

Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results

GlobeNewswire
·
Mar 13

Erasca: Pan-RAS Data Momentum and Strategic Partnerships Underpin Upsized Revenue Outlook and Buy Rating

TIPRANKS
·
Mar 11

Erasca price target raised to $20 from $10 at Stifel

TIPRANKS
·
Mar 11

Erasca Exercises Option to Extend Cancer Drug Candidate License to Gain Global Rights

MT Newswires Live
·
Mar 10

Erasca Inc - Initial Phase 1 Monotherapy Data for Eras-0015 Expected in H1 2026

THOMSON REUTERS
·
Mar 10

Erasca Inc - Exercises Option to Secure Worldwide Rights for Eras-0015

THOMSON REUTERS
·
Mar 10

Erasca expands ERAS-0015 license to secure worldwide rights including China, Hong Kong and Macau

Reuters
·
Mar 10

Erasca Chief Medical Officer Morris Shannon Disposes of Common Shares

Reuters
·
Mar 06

Erasca Is Maintained at Buy by Clear Street

Dow Jones
·
Mar 06

Erasca price target raised to $20 from $11 at Clear Street

TIPRANKS
·
Mar 06

These stocks are set for high-stakes earnings moves. Here's your trading playbook.

Dow Jones
·
Mar 06

Erasca, Tango Therapeutics Partner on Phase 1/2 Trial for Combination Cancer Therapy

MT Newswires Live
·
Mar 05